The humoral immune response to tumour antigens is difficult to investigate. Firstly, relevant specific anti-tumour antibodies may not be detected in serum because they are already bound to circulating tumour-associated antigens or to anti-idiotypic antibodies. Secondly, the specific reactivity of such anti-tumour serum antibodies with tumourassociated antigens may be masked by the reactivity of other antibodies with non-specific antigens expressed by the tumour cells.
EBV infection is known to transform human lymphocytes which have recently been exposed to relevant antigens (Steinitz et al., 1979) . This phenomenon, together with cell fusion experiments, has been exploited to perform in vitro studies of the anti-tumour humoral immune response in a variety of non-ocular neoplasms (Cote et al., 1986; Houghton et al., 1983; Campbell et al., 1986) . Such an experimental approach has another advantage, at least in theory: relevant B-lymphocytes could be propagated indefinitely in vitro for the production of human monoclonal antibodies and these antibodies could then be used to investigate the nature of the tumour-associated antigens that are stimulating the immune response. This approach has not previously been applied to the study of ocular melanomas.
In this study, the EBV transformation technique was used to investigate the B-lymphocyte reactivity of patients with uveal melanoma against autologous melanoma cells and autologous normal lymphocytes. In addition, the Blymphocyte reactivity with allogeneic melanoma cells was measured in patients with uveal melanoma and in healthy individuals. The significance of the results obtained was investigated by measuring the apparent B-lymphocyte reactivity with antigens which were unlikely to have been encountered previously by the individuals being tested. These were plant protoplasts from the tobacco plant as a cellular control, keyhole limpet haemocyanin as a purified protein control, and schistosome whole worm antigen as a complex mixture of foreign protein and carbohydrate.
We report here the findings of this investigation of the humoral immune response to uveal melanoma.
Materials and methods
Preparation and transformation of human B-lymphocytes A single venous blood sample was obtained from 12 patients with uveal melanoma and from 5 healthy individuals. Two venous blood samples were taken from an additional patient with uveal melanoma for use in a reproducibility study.
Each blood sample (10-20 ml) was added to an equal volume of 2% foetal calf serum (FCS) layered over an equal volume of Ficoll-Paque, and centrifuged at 300g for 15 min at room temperature. The cells at the fluid interface were harvested, washed in RPMI medium, and counted. They were then incubated at a concentration of 107 cells ml -for 1 h with EBV obtained from the supernatant of the B95-8 marmoset cell line (Miller & Lipman, 1973) , then washed and aliquoted at 105 cells/well in the central 60 wells of a 96-well Costar plate. CyclosporinA, 1 ,g ml-', was added to the 20% FCS medium to inhibit Tcell activity (Shevach, 1985) so that suppression of B-cell growth would be prevented (Bird et al., 1981) . The transformed lymphocytes (transformants) were fed with fresh medium at weekly intervals. Supernatants were removed for assay in the interval spanning 10-21 days, during which time the cells continue to secrete large amounts of antibody.
Derivation of antigens Relevant antigens Blocks of uveal melanoma tissue (5 x 4 x 4 mm) were excised from 15 fresh tumours which were treated either by local surgical resection (Foulds, 1978) or by enucleation. Using the plunger of a disposable 10ml syringe, the tumour tissue was passed through a stainless steel wire mesh into a 6cm petri dish containing RPMI. A sample of the cell suspension was counted with a Neubauer haemocytometer and the integrity of the cells was determined by examining a parallel sample by phase contrast microscopy.
Irrelevant antigens Protoplasts were prepared from Nicotiana plumbaginifolia (tobacco plant) by the method of Sidorov and Maliga (1982) . Keyhole limpet haemocyanin (KLH) was purchased from Sigma Chemicals, Poole, Dorset. Schistosome whole adult worm antigen was prepared by homogenisation of whole worms from Schistosoma mansonai in phosphate buffered saline followed by centrifugation at 500g after 16h incubation at room temperature, and was a gift from Dr Janet Jones, Department of Biochemistry, University of Glasgow.
Enzyme-linked immunosorbent assay (ELISA)
The ELISA was similar to that described by Effros and associates (1985) . Flat-bottomed, 96-well microtitre plates were rinsed briefly in warm distilled water. Aliquots of a cell suspension, consisting of 104 cells/!100 ug, were dispensed to all wells with the exception of row 1 of the plate. The plates were incubated in air at 37°C until they were completely dry and then wrapped in clingfilm and stored at 4°C until use. KLH and schistosome whole worm antigen were applied to the wells at concentrations of lO jug 1OO ud l and 2 ,g 100 pl 1 respectively and incubated for 16 h at 4°C. The plates were then washed with PBS containing 0.05% Tween Br. J. Cancer (1988), 58, 182-185 and incubated with 100 ,l transformant for 16 h at 4°C, After a further wash, the wells were incubated with 100,l horseradish peroxidase-labelled rabbit anti-human IgG (H + L) (Dako) for 30 min at room temperature. This reagent detected IgM as well as antibodies by reaction with the constant region of the light chains. The wells were washed again and incubated with 100 pi orthophenylene diamine (0.4mgml-1 in 0.01% H202). The reaction was arrested by the addition of 50,pl 4N H2SO4 and the light absorbance read at 492 nm using a Titretek Multiskan spectrophotometer. Six control wells on each plate contained 20% FCS instead of the transformant supernatant. Results greater than three standard deviations of the mean of the 6 control readings were considered to be positive.
Reproducibility study A sample of venous blood was divided into two aliquots from which two preparations of lymphocytes were extracted. These were EBV-transformed separately and then assayed simultaneously on two different allogeneic uveal melanomas. One day after the first two transformations, EBVtransformation was performed on lymphocytes from a second blood sample from the same patient, and assayed against cells from the same two allogeneic uveal melanomas.
Reactivity with autologous melanoma cells and lymphocytes
The reaction of the peripheral B-cells of 5 patients with uveal melanoma was simultaneously tested against autologous tumour and B-lymphocytic cells.
Reactivity with allogeneic melanoma cells and lymphocytes
The reactions of peripheral B-lymphocytes of 5 patients with uveal melanoma and 5 healthy individuals were tested against allogeneic melanoma cells.
Reactivity with irrelevant antigens
The reactivities of peripheral B-lymphocytes of 2 patients with uveal melanoma and one healthy individual were tested against plant protoplasts, keyhole limpet haemocyanin and schistosome whole worm antigen. In each case, uveal melanoma was used as a positive control.
Results

Reproducibility study
The reactivity of B-lymphocytes of patient JB with melanoma cells of patient MT was stronger than the reactivity with the melanoma cells of patient JS (Figure 1 ). The two lymphocyte preparations derived from the same blood sample showed good repeatability, that is, to within 10%. The lymphocyte preparation derived from the second blood sample showed good repeatability when tested against patient JS (i.e. 0-3%) and moderate repeatability when tested against patient MT (i.e. 13-18%).
Reactivity with autologous melanoma cells and lymphocytes Three patients apparently reacted more strongly with the melanoma cells whereas 2 patients reacted more strongly with the lymphocytes (Figure 2 ).
Reactivity of patients and healthy individuals with allogeneic melanoma cells
The reactivity of the healthy individuals with the tumour cells was almost as strong as that seen in the patients with uveal melanoma (Figure 3 ). Figure 4 shows the reactivity of 3 individuals with irrelevant antigens consisting of plant protoplasts, keyhole limpet haemocyanin and adult schistosome whole worm antigen. Positive reactivity was seen with all 3 antigens.
Reactivity with irrelevant antigens
Discussion
Patients with uveal melanoma showed equal B-lymphocyte reactivity with autologous tumour cells and autologous lymphocytes. This suggested that the recognised antigens were not necessarily melanoma-associated. Other studies have apparently shown that patients with uveal melanoma and other types of malignancy have serum antibodies which are reactive with normal intracellular proteins (Malaty et al., 1979) .
The reactivity of the peripheral blood B-lymphocytes of healthy individuals with melanoma cells was very variable and similar to the allogeneic reactivity seen in patients with uveal melanoma. It is known that antibodies reactive with tumour-associated and normal tissue antigens occur in healthy individuals (Houghton et al., 1980) . Furthermore, monoclonal antibodies reactive with tumours and established autoantigens have previously been generated from unimmunised human individuals (Shoenfeld & Witz, 1986; Winger et al., 1983) . Such findings have given rise to speculation that these autoantibodies play a role in the regulation of the idiotypic network of both B-and T-lymphocytes (Schoenfeld & Witz, 1986) .
Although the measurement of B-lymphocyte reactivity with melanoma cells from any individual tumour showed good to moderate reproducability, inconsistent results were obtained when the ELISA was simultaneously performed with different uveal melanomas. A similar observation was made previously (Damato et al., 1986) and is likely to be due to inter-tumour antigenic heterogeneity, which is a well recognised phenomenon (Miller, 1982; Natali et al., 1983; Heppner, 1984; Edwards, 1985) .
The finding that B-lymphocyte-derived antibodies also reacted significantly with foreign antigens that were unlikely to have been encountered previously is not consistent with the hypothesis that auto-antibodies play useful roles in vivo. It may be argued that such results are an artefact of the ELISA, but such antibodies have been shown to react with intracellular material by other assays, such as immunofluorescence microscopy and immunoblotting (Cote et al., 1986) .
A possible explanation for the results of this study is that the antigens are wrongly identified by the antibodies that are secreted by the transformed B-lymphocytes. In human hybridoma technology, whether or not EBV transformation is employed, the great majority of immortalised lymphocytes secrete antibody of the IgM isotype (Steel et al., 1977; Chan et al., 1986; Cote et al., 1986) . This antibody, being multivalent, can react spuriously with various antigens in a 'multispecific' fashion because any low affinity interactions with such antigens will be amplified by local concentration effects (Ghosh & Campbell, 1986; Campbell et al., 1987) . The probability of this irrelevant type of non-specific reaction is increased when antigens have high epitope densities with a repeating structure offering a wide variety of regularly spaced epitopes. Such antigens include single stranded DNA, actin, myosin and vimentin (Ghosh & Campbell, 1986) .
Multispecific antigen-antibody reactions, such as those seen in the present study, could account for the findings of previous investigations into the immunology of uveal melanoma. Serum IgM antibodies apparently reactive with intracellular proteins, such as actin, for example (Malaty ei al., 1979) , could be directed against totally irrelevant antigens, such as bacterial and viral antigens. It is also conceivable that multispecific reactions with abundant cytoplasmic proteins have masked the presence of any antibodies directed against melanoma-associated membrane antigens. These considerations are also relevant in the production of rodent and human monoclonal antibodies to melanoma in that the apparent lack of specificity of an antibody could be due to multispecific reactivity rather than the expression of the target antigen in irrelevant cells.
Until such factors are taken into account, possibly by focusing attention on IgG antibodies reacting with autologous living cells, the existence of an in vivo humoral immune response to uveal melanoma will remain unproven.
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